CD10-bearing fibroblast inhibits matrigel invasive potency of interleukin-1α-producing squamous cell carcinoma by diminishing substance P levels in the tumor microenvironment

Cancer Science

Volumn 101, Issue 12, 2010, Pages 2570-2578

  Xie, Lining ^a   Moroi, Yoichi ^a   Tsuji, Gaku ^a   Liu, Min ^b   Hayashida, Sayaka ^a   Takahara, Masakazu ^a   Fukagawa, Shuji ^a   Takeuchi, Satoshi ^a   Shan, Baoen ^c   Nakahara, Takeshi ^a   Uchi, Hiroshi ^a   Yokomizo, Takehiko ^b   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; INTERSTITIAL COLLAGENASE; MATRIGEL; SMALL INTERFERING RNA; SUBSTANCE P;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL INTERACTION; CELL INVASION; COCULTURE; CONTROLLED STUDY; ENZYME REGULATION; ENZYME SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN FIBROBLAST; SQUAMOUS CELL CARCINOMA; SUPERNATANT; TUMOR MICROENVIRONMENT; UPREGULATION;

BIOCOMPATIBLE MATERIALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SEPARATION; COLLAGEN; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1ALPHA; LAMININ; NEOPLASM INVASIVENESS; NEPRILYSIN; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SUBSTANCE P; TRANSFECTION; TUMOR MICROENVIRONMENT;

EID: 78449278461     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01735.x     Document Type: Article

References (42)

1. Lorusso G, Rüegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 2008; 130: 1091-103.
2. Hanna E, Quick J, Libutti SK. The tumour microenvironment: a novel target for cancer therapy. Oral Dis 2009; 15: 8-17.
3. Nielsen JD, Moeslund M, Wandall HH, Dabelsteen S. Influences of tumor stroma on the malignant phenotype. J Oral Pathol Med 2008; 37: 412-6.
4. Tlsty TD. Stromal cells can contribute to oncogenic signals. Semin Cancer Biol 2001; 11: 97-104.
5. Coussens L, Werb Z. Inflammatory cells and cancer. J Exp Med 2001; 193: 23.
6. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978; 276: 523-6.
7. Stimler-Gerard NP. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J Clin Invest 1987; 79: 1819-25.
8. King KA, Hua J, Torday JS et al. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest 1993; 91: 1969-73.
9. Adams H, Tzankov A, D'Hondt S, Jundt G, Dirnhofer S, Went P. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors. Hum Pathol 2008; 39: 1323-30.
10. Alacacioglu I, Ozcan MA, Ozkal S et al. Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma. Hematology 2009; 14: 84-9.
11. Dakka N, Bellaoui H, Bouzid N, Khattab M, Bakri Y, Benjouad A. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome. Pediatr Hematol Oncol 2009; 26: 216-31.
12. Albrecht M, Gillen S, Wilhelm B et al. Expression, localization and activity of neutral endopeptidase in cultured cells of benign prostatic hyperplasia and prostate cancer. J Urol 2002; 168: 336.
13. Iwaya K, Ogawa H, Izumi M et al. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002; 440: 589.
14. Kesse-Adu R, Shousha S. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma. Mod Pathol 2004; 17: 646.
15. Ogawa H, Iwaya K, Izumi M et al. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002; 33: 806.
16. Tokuhara T, Adachi M, Hashida H et al. Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 2001; 49: 489.
17. Xie LN, Uchi H, Hayashida S et al. Stromal CD10 expression is correlated with invasiveness and proliferation of extramammary Paget disease. Br J Dermatol 2008; 158: 1389-91.
18. Takahara M, Chen SJ, Kido M et al. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes. J Cutan Pathol 2009; 36: 668-74.
19. Stefano GB, Paemen LR, Hughes TK Jr. Autoimmunoregulation: differential modulation of CD10/neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides. J Neuroimmunol 1992; 41: 9-14.
20. Lu B, Gerard NP, Kolakowski LF Jr et al. Neutral endopeptidase modulation of septic shock. J Exp Med 1995; 181: 2271-5.
21. Sio SW, Puthia MK, Lu J, Moochhala S, Bhatia M. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury. J Immunol 2008; 180: 8333-41.
22. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
23. Anton K, Gold J. Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 2009; 10: 185-91.
24. Albini A, Iwamoto Y, Kleinman HK et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
25. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
26. Santon JB, Cronin MT, MacLeod CL, Mendelsohn J, Masui H, Gill GN. Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res 1986; 46: 4701-5.
27. Esteban F, Muñoz M, González-Moles MA, Rosso M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev 2006; 25: 137-45.
28. Esteban F, Gonzalez-Moles MA, Castro D et al. Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression. Histopathology 2009; 54: 258-60.
29. Spaeth EL, Dembinski JL, Sasser AK et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 2009; 4: e4992.
30. Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 2009; 8: 589-95.
31. Delgado AV, McManus AT, Chambers JP. Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med 2005; 230: 271-80.
32. Muangman P, Tamura RN, Muffley LA et al. Substance P enhances wound closure in nitric oxide synthase knockout mice. J Surg Res 2009; 153: 201-9.
33. Wang FM, Hu T, Cheng R, Tan H, Zhou XD. Substance P influenced gelatinolytic activity via reactive oxygen species in human pulp cells. Int Endod J 2008; 41: 856-62.
34. Cury PR, Canavez F, De Araújo VC, Furuse C, De Araújo NS. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts. J Periodontal Res 2008; 43: 255-60.
35. Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004; 17: 1251-8.
36. Matsuo Y, Sawai H, Ma J et al. IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells' potential for liver metastasis. J Surg Oncol 2009; 99: 361-7.
37. Graziano F, Ruzzo A, Canestrari E et al. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. Pharmacogenomics J 2009; 9: 78-84.
38. Chen Z, Malhotra PS, Thomas GR et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999; 5: 1369-79.
39. Wolf JS, Chen Z, Dong G. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001; 7: 1812-20.
40. Delikat SE, Galvani DW, Zuzel M. A function of CD10 on bone marrow stroma. Br J Haematol 1994; 87: 655-7.
41. Terauchi M, Kajiyama H, Shibata K et al. Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo. Oncology 2005; 69: 52-62.
42. Dai J, Shen R, Sumitomo M et al. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res 2001; 7: 1370-7.